Symptom Monitoring System for Childhood Cancer
(SyMon-SAYS Trial)
Trial Summary
What is the purpose of this trial?
This proposed study plans to develop and evaluate a patient-oriented, technology-based, symptom monitoring system that reports symptoms experienced by children with cancer to their parents and health care providers.
Research Team
Jin-Shei Lai, PhD
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for children aged 8-17 with cancer, including brain tumors, who are currently receiving treatment or have completed therapy within the last 6 months. They must be able to understand and use English to give consent and interact with a symptom monitoring system on an electronic device.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Group A participants receive the SyMon-SAYS intervention every week for 16 weeks. Group B participants receive usual care for 8 weeks, then the intervention for 8 weeks.
Follow-up
Participants are monitored for changes in symptom management barriers, symptom burden, HRQOL, and self-efficacy.
Treatment Details
Interventions
- SyMon-SAYS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
National Cancer Institute (NCI)
Collaborator